The Global Health Policy Center leads CSIS’s research bridging foreign policy and public health communities.

Image
Photo: Corona Borealis/Adobe Stock

Photo: Corona Borealis/Adobe Stock

The United States Cannot Afford Disarray as China Strengthens Its Biopharmaceutical Industry

The United States should remember that leadership in biopharmaceutical innovation is driven by its unparalleled R&D ecosystem. Arbitrary changes in funding and rules threaten U.S. bioinnovation leadership and the nation’s health, welfare, and national security.

Commentary by Sujai Shivakumar, Charles Wessner, and Julie Heng — March 18, 2025

Past Events


Related Programs


Experts


Image
Katherine E. Bliss
Senior Fellow and Director, Immunizations and Health Systems Resilience, Global Health Policy Center
Image
Bhawna Prakash
Senior Fellow, Water and Sanitation, Chair on India and Emerging Asia Economics
Image
Jon B. Alterman
Deputy Director, Global Food and Water Security Program